# Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )

> **NCT04119986** · NA · NOT_YET_RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 220 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** drug coated balloon
- **DEVICE:** drug eluted stent

## Key facts

- **NCT ID:** NCT04119986
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119986, "Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04119986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*